Jacobs Levy Equity Management’s Biote Corp BTMD Stock Holding History

Jacobs Levy Equity Management’s Portfolio BTMD Stock Details BTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$81.1K	Sell	42,916 -108,133	-72%	-$223K	﹤0.01%	927
2026 Q1	$204K	Buy	151,049 +52,444	+53%	+$105K	﹤0.01%	917
2025 Q4	$256K	Sell	98,605 -44,125	-31%	-$121K	﹤0.01%	871
2025 Q3	$428K	Sell	142,730 -79,826	-36%	-$285K	﹤0.01%	838
2025 Q2	$895K	Sell	222,556 -13,351	-6%	-$49.3K	﹤0.01%	777
2025 Q1	$786K	Sell	235,907 -34,568	-13%	-$165K	﹤0.01%	855
2024 Q4	$1.67M	Sell	270,475 -1,902	-0.7%	-$11.1K	0.01%	631
2024 Q3	$1.52M	Buy	272,377 +54,302	+25%	+$362K	0.01%	655
2024 Q2	$1.63M	Buy	+218,075	New	+$1.35M	0.01%	642

Other funds holding BTMD

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

Bandera Partners New York $284M AUM 33.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management's BTMD Position: Q2 2026 in Review

Jacobs Levy Equity Management reduced its Biote Corp (BTMD) stake by 72% in Q2 2026, selling an estimated $223K and leaving 42,916 shares worth $81.1K. The position accounts for ﹤0.01% of the portfolio, ranked #927.

Jacobs Levy Equity Management first reported a position in BTMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.67M in Q4 2024. 71 funds tracked by Wall St. Rank hold BTMD as of Q2 2026.

Jacobs Levy Equity Management held 42,916 shares of Biote Corp worth $81.1K as of Q2 2026.
Jacobs Levy Equity Management sold 108,133 Biote Corp shares in Q2 2026, an estimated $223K.
Biote Corp made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #927 holding.
Jacobs Levy Equity Management first reported a position in Biote Corp in Q2 2024 and has held it in 9 quarters since.
Jacobs Levy Equity Management's Biote Corp position peaked at $1.67M in Q4 2024.
71 funds tracked by Wall St. Rank held Biote Corp as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.